<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Mon, 11 Aug 2025 06:53:23 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>3 Dividend Stocks Raising Payouts—and Backing It Up With Results</title><link>https://www.marketbeat.com/stock-ideas/3-dividend-stocks-raising-payoutsand-backing-it-up-with-results/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Three companies are increasing their dividend payouts to show strength in their underlying financials, as well as potential upside in the coming month...</description><pubDate>Sun, 10 Aug 2025 09:43:00 GMT</pubDate></item><item><title>3 Stocks With Monopoly Power—and Minimal Competition</title><link>https://www.marketbeat.com/stock-ideas/3-stocks-with-monopoly-powerand-minimal-competition/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Three near-monopoly companies have been left behind as hotter names have taken over investor attention recently, creating upside opportunities.</description><pubDate>Sun, 10 Aug 2025 08:47:00 GMT</pubDate></item><item><title>Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact?</title><link>https://www.marketbeat.com/originals/rocket-lab-reports-q2-results-is-the-bull-thesis-still-intact/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Despite missing EPS estimates, RKLB delivered strong Q2 2025 revenue results, with sales up 36% YoY, driven by launch activity and satellite growth.</description><pubDate>Sat, 09 Aug 2025 10:02:00 GMT</pubDate></item><item><title>Trump GLP-1 Pilot Program Could Boost Novo Nordisk &amp; Eli Lilly</title><link>https://www.marketbeat.com/stock-ideas/trump-glp-1-pilot-program-could-boost-novo-nordisk-and-eli-lilly/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png</image_url><description>Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif...</description><pubDate>Sat, 09 Aug 2025 10:00:00 GMT</pubDate></item><item><title>Now Is a Great Time to Buy Cheniere Energy: New High Expected</title><link>https://www.marketbeat.com/originals/now-is-a-great-time-to-buy-cheniere-energy-new-high-expected/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Cheniere Energy is well-positioned to benefit from rising LNG demand globally, delivering capital to shareholders the entire time.</description><pubDate>Sat, 09 Aug 2025 09:01:00 GMT</pubDate></item></channel></rss>